BIIB vs MYRG · P/E 21, rev $9.89B vs P/E 51, rev $2.08B
Biogen Inc (BIIB) versus MYR Group Inc (MYRG) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
MYR Group Inc (MYRG) is a engineering & construction company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported MYRG revenue for 2026-06-30 was $2.08B. Net income was $96.7M. MYRG currently screens at market cap $7.24B and trailing P/E 51.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. MYRG currently screens at market cap $7.24B and trailing P/E 51.3.
Not investment advice. Open the BIIB and MYRG stock pages for the full models.
Not investment advice.